Galmed Pharmaceuticals (GLMD) Q3 2024 Earnings
GLMD·Reported November 14, 2024·Before market open
Diluted EPS came in at $-2.31.
Diluted EPS
$-2.31
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Galmed Pharmaceuticals's Q3 2024 earnings report.
Galmed Pharmaceuticals (GLMD) reported Q3 2024 earnings on November 14, 2024 before market open.
Galmed Pharmaceuticals reported diluted EPS of $-2.31 for Q3 2024.